Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Cytokinetics Inc (NASDAQ: CYTK) closed the day trading at $55.98 down -0.57% from the previous closing price of $56.30. In other words, the price has decreased by -$0.57 from its previous closing price. On the day, 1.17 million shares were traded. CYTK stock price reached its highest trading level at $57.395 during the session, while it also had its lowest trading level at $55.54.
Ratios:
For a better understanding of CYTK, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.19 and its Current Ratio is at 7.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on January 24, 2024, Downgraded its rating to Neutral and sets its target price to $92 from $61 previously.
On January 05, 2024, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight and also upped its target price recommendation from $60 to $90.
On November 09, 2023, Goldman started tracking the stock assigning a Buy rating and target price of $50.Goldman initiated its Buy rating on November 09, 2023, with a $50 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 10 ’24 when Blum Robert I sold 11,500 shares for $54.29 per share. The transaction valued at 624,335 led to the insider holds 399,412 shares of the business.
Malik Fady Ibraham sold 7,300 shares of CYTK for $408,103 on Jul 09 ’24. The EVP Research & Development now owns 131,004 shares after completing the transaction at $55.90 per share. On Jul 05 ’24, another insider, Harrington Robert Arthur, who serves as the Director of the company, sold 253 shares for $54.61 each. As a result, the insider received 13,816 and left with 15,516 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CYTK now has a Market Capitalization of 6558202368 and an Enterprise Value of 6005679104. For the stock, the TTM Price-to-Sale (P/S) ratio is 1711.64. Its current Enterprise Value per Revenue stands at 1600.661 whereas that against EBITDA is -12.368.
Stock Price History:
Over the past 52 weeks, CYTK has reached a high of $110.25, while it has fallen to a 52-week low of $25.98. The 50-Day Moving Average of the stock is 0.36%, while the 200-Day Moving Average is calculated to be -1.74%.
Shares Statistics:
Over the past 3-months, CYTK traded about 2.03M shares per day on average, while over the past 10 days, CYTK traded about 1779840 shares per day. A total of 114.66M shares are outstanding, with a floating share count of 110.89M. Insiders hold about 3.29% of the company’s shares, while institutions hold 101.11% stake in the company. Shares short for CYTK as of 1719532800 were 17377857 with a Short Ratio of 8.58, compared to 1717113600 on 16424705. Therefore, it implies a Short% of Shares Outstanding of 17377857 and a Short% of Float of 22.709998000000002.
